Skip to main content
  • Cytoreductive Surgery in the Management of Newly Diagnosed Glioblastoma in Adults: A Systematic Review and Evidence‑based Clinical Practice Guideline Update

    Length: 22:52

    Glioblastoma (GBM) continues to be a challenging disease to treat, often with rapid progression and limited overall survival. Surgical resection is central to treatment paradigms in combination with radiation therapy and chemotherapy for treatment of newly diagnosed glioblastoma. Authors discuss the evidence in newly available literature since the original guideline was published in 2008, and the recent updates to the recommendations regarding cytoreductive surgery.

    Click here to access the guideline.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy